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Mitokondrio on solujen aerobisen energian tuotannon kannalta tärkeä kaksi kalvoinen soluorganelli. Sen sisällä 
tapahtuva sitruunahappokierto tuottaa elektroneja elektronin siirtoketjuun, jota tarvitaan oksidatiiviseen fosforylaatioon. 
Nämä elektronit kulkevat mitokondrion sisäsolukalvolla tiettyjen proteiinikompleksien I, II and IV läpi joiden 
koentsyymeinä toimii ubikinoni ja sytokromi C. Tämä johtaa pelkistysreaktio sarjaan, jossa elektronien siirto aiheuttaa 
elektrokemiallisen protonigradientin solukalvojen väliseen tilaan. Gradientin potentiaalista energiaan käyttäen ATP-
syntaasi proteiini tuottaa ATP:ta.  
Pieni osa elektroneista vuotaa kompleksista I ja II ja reagoivat hapen kanssa muodostaen reaktiivisia happiradikaaleja, 
jotka reagoidessaan aiheuttavat kumulatiivisesti muun muassa mutaatioita mitokondrio DNA:han ja ovat osittain 
vastuussa vanhenemisesta. Nykyinen tieto näyttää, että vaikka happiradikaalit voivat vahingoittaa DNA:ta ja johtaa 
mutaatioihin, tämä ei ole verrannollinen happiradikaalien määrään. Tämä korostaa mitokondriaalisen DNA:n huollon 
merkitystä vanhenemisessa. Mitokondriaalinen DNA eroaa nukleaarisesta DNA:sta sen äidillisen periytyvyyden kautta 
ja sen suuresta kopiomäärästä per solu, joka voi johtaa tilanteeseen, jossa yhdessä solussa on mutaation kautta eri 
genomia sisältävää mitokondriaalista DNA:ta. Mitokondrion mutaatioilla on yhteyksiä moniin neurologisiin ja 
metabolisiin sairauksiin. 
Ei ole olemassa hyvää työkalua muokata mitokondriaalista DNA:ta in vivo, joiden avulla voitaisiin ymmärtää 
mitokondriaalisia mutaatiota paremmin. Ryhmämme alkoi tutkimaan EcoBI tyypin 1 restriktioentsyymikompleksia, 
joka voi saada aikaan kahden ketjun katkoksia mitokondriaaliseen DNA:han. Mitokondrion korjaus mekanismin 
epätäydellisen luonteen vuoksi tämä altistaa mutaatioilla ja näin toimisi in vivo satunnaismutaattorina. EcoBI systeemiin 
on istutettu Drosophila melanogasterin (banaanikärpänen) mitokondrionaaliseen DNA:han ja risteytimme ne DJ-694-
geeniaktivaattorin kanssa. Tämä promotoi EcoBI geeniä banaanikärpäsen lihaskudoksissa, johtaen lentokyvyn 
häviämiseen ja aikaiseen kuolemaan. Analysoimme kärpästen proteiinia westernblot-menetelmällä, DNA:n lukumäärää 
ja RNA:n expressioita kvantitatiivisella reaaliaikaisella PCR:llä. Kontrollina käytimme inaktiivista EcoBI R-
alayksikköä omaavaa kärpästä. 
Havaitsimme kompleksi I:n alayksikön määrän laskun naaras, että uros kärpäsillä, viitaten kompleksi I:n alentuneeseen 
määrään. Mitokondriaalisen DNA:n lukumäärässä havaitsimme selvän nousun. Mitokondrion geeniekspressiossa 
havaitsimme eroja useassa geenisssä, kontrolliryhmään verrattuna. Nämä ovat vasta alustavia vastauksia, jotka 
vahvistavat EcoBI:n kykyä vaikuttaa mitokondrion toimintaan ja ekspressioon. 
_______________________________________________________________ 
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Introduction 
 
The mitochondrion is an energy ”power plant”  present in nearly all eukaryotic organisms, which 
arose from a symbiotic relationship between a bacterium and a primitive eukaryotic cell.  It is a 
double membrane organelle, with an intermembrane space and an inner space called the matrix. The 
inner membrane forms folded structures called cristae, giving the mitochondria a distinguishable 
structure visible under an electron microscope and increasing the surface area necessary for 
oxidative phosphorylation (OXPHOS). The mitochondria supplies the cell with adenosine 
triphosphate (ATP) by oxidative phosphorylation of adenosine diphosphate (ADP) through the 
action of the electron transport chain. This allows 15 times more ATP to be produced compared to 
anaerobic glycolysis per glucose molecule.  
Glycolysis and inside the matrix the citric acid cycle provide electrons via coenzymes reduced 
nicotinamide adenine dinucleotide (NADH) and reduced flavin adenine dinucleotide FADH2 for the 
electron flow required for OXPHOS. The citric acid cycle (also called tricarboxylic acid cycle or 
Krebs cycle) oxidates acetyl groups in acetyl coenzyme A through a series of reactions that involve 
transferring the acetyl group to oxaloacetate and forming citrate acid which is then oxidized in a 
series of steps back to oxaloacetate and CO2. A complete cycle generates 3 NADH, FADH2 and 
guanosine triphosphate (GTP) which transfers a phosphate group to ADP and forms ATP. 
The acetyl groups are produced by catabolization of sugars through glycolysis, fatty acids via beta 
oxidation and amino acids. In the inner mitochondrial membrane the electrons from the citric acid 
cycle are passed through a series of protein complexes I, III and IV and electron transporters 
ubiquinone and cytochrome C. This results in a series of redox reactions using the flow of electrons 
to pump protons into the intermembrane space. Complex IV transports the electrons finally to 
oxygen. The pumping of protons creates an electrochemical proton gradient between the 
intermembrane space and mitochondrial matrix. This potential energy is used by the ATP synthase 
protein to form ATP from phosphate ions inside the matrix. (1, 2) 
Small percentage of electrons do not follow the predisposed path through the electron transport 
chain (ETC) complexes and “leak” from complex I and complex III. They react with oxygen to 
form a superoxide radical, the first precursor molecule of highly reactive group of molecules called 
reactive oxygen species (ROS).  The mitochondrial free radical theory of ageing claims that damage 
from mitochondrial ROS is the underlying cause of senescence in the living organisms (3, 4). The 
theory states that ROS damages accumulates throughout life span, causing among other things an 
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increase in mutations in mitochondrial DNA (mtDNA) which in turn will result in abnormal 
electron transport chain complexes with mutated subunits producing  even higher  amount of ROS, 
which leads to ageing. 
 Mitochondrion has an important role in the apoptosis of the cell, triggered by cell or DNA damage 
or signals from nearby cells. Apoptosis is from of programmed cell death (PCD) that provides a 
path for exterminating malign cells.  Release of cytochrome C from matrix to cytosol triggers the 
downstream caspase cascade and activates PCD pathway. Mitochondria have also been implicated 
in tumorigenesis, where energy production is shifted in cancer cells from oxidative phosphorylation 
to glycolysis (Warburg effect) even in an aerobic environment, which might be caused by mtDNA 
damage. (5-8) 
  The mitochondrion respiratory chain consists of subunits mainly synthesized from nuclear DNA 
and some from mtDNA. Mitochondrial DNA defects can be linked to a number of diseases such as 
chronic progressive external ophthalmoplegia (CPEO), Kearns–Sayre syndrome, mitochondrial 
diabetes mellitus and mitochondrial deafness (9, 10). It also been proposed that preventation of 
mtDNA damage could be used for treatment in cardiovascular disease (10). In addition, because of 
its role as a nexus of metabolic regulation in cell, mitochondrial dysfunctions are linked to several 
other chronic and degenerative diseases (12, 13) 
The mtDNA differs from nuclear DNA not only by its maternal inheritance but also by its copy 
number per cell (100-1000). This results in a phenomenon called heteroplasmy, where mutated 
mtDNA populations exist alongside wild-type mtDNA. In several cases the severity of symptoms of 
mitochondrial diseases are directly related to percentage of heteroplasmy – the higher the ratio of 
mutated mtDNA, the more severe the symptoms. Current data suggests that although ROS can 
damage DNA and lead to accumulation of mutations, the profile of mtDNA mutations accumulating 
during aging is not consistent with ROS damage. This suggests that mtDNA maintenance, not 
chemical damage by ROS, has a highly important role in damage accumulation during aging. For 
instance a mutated mouse model expressing mtDNA proof-reading deficient polymerase leads to 
increased point mutations and rapid ageing. (14) However this is not associated with increased 
ROS. 
 
Therefore, proper maintenance of the mitochondrial genome is important to organismal 
homeostasis, ageing and a variety of disease states. In vivo modification of mtDNA would be an 
ideal tool to understand the process of mitochondrial dysfunction. However, no mtDNA 
mutagenesis system akin to approaches used to modify nuclear genome currently exists. Previous 
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attempts to change mtDNA in higher eukaryotes have not had a reliable delivery system, inefficient 
integration into mt genome and active negative selection against the modified mtDNA. 
Mitochondrial transformation in vivo has only been achieved for Saccharomyces cerevisiae (baking 
yeast), while delivery to mitochondria in mammalian cell cultures has been limited to nucleic acid 
analogues (15-17). Transformations by means of bacterial conjugation, electroporation and natural 
competency have been reported only to isolated organelles. (18-20).   
A new approach has been explored for mtDNA manipulation wherein exogenous or mutated 
endogenous DNA-modifying enzymes are targeted to the mitochondrial matrix, allowing on-site 
manipulation of mtDNA within living organisms. Several Type II or tailored zinc-finger/TALEN 
nucleases have been used successfully to cleave mtDNA in vivo. (21, 22) However, such approach 
is limited by the fact that they cut at their recognition sequence only.  
 
  
    
My project is associated with the research of postdoctoral fellow Priit Joers in Mitochondrial 
Disease and Gene Expression group titled “Design and development of a novel mitochondrial 
mutator system based on mitochondrially targeted EcoBI (mtEcoBI) restriction complex in 
Drosophila melanogaster.” EcoBI is a type I restriction enzyme complex that can promote double 
strand breaks (DSB) at random positions throughout the Drosophila mitochondrial genome 
(contains three binding sites for EcoBI) due to its ability to translocate DNA template. It is proven 
that DSBs can stimulate recombination in mtDNA (23-25). The EcoBI multisubunit enzyme 
complex consists of three subunits (R, M and S) with stoichiometry of S1M2R2. The S subunit 
binds to the target site, the M methylates hemimethylated sites and the R is responsible of 
translocation and cleavage of DNA. Endogenous reapir mechanisms in D.melanogaster 
mitochondria can repair the EcoBI-inflicted double strand breaks to the mtDNA. However, due to 
the imperfect nature of repair process, spontaneous mutations will arise at these break points. We 
aim to generate an in vivo mitochondrial mutator system capable of random mutagenesis throughout 
the mitochondrial genome and utilize this system to advance our understanding of mitochondrial 
function. 
The EcoBI system was targeted to the mitochondrial genome in the D.melanogaster by adding a 
mitochondrial targeting sequence from citrate synthase to original bacterial genes. The model 
organism D.melanogaster is ideal for our needs since it has a short lifespan, high reproduction rate 
and relatively cheap upkeep. Type I subunit genes were placed under the control of GAL4-
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responsive expression system, which allowed us to have temporal and spatial control over the 
expression of EcoBI by using different GAL4-based Drosophila “drivers”. These are DNA 
constructs where GAL4 transcriptional activator is expressed from specific native promoters, thus 
activating EcoBI in the tissues and developmental stages where given promoter is functional  A 
daGAL4 driver which gives a strong ubiquitous expression leads to the death of embryos and only a 
few larvae hatch but never develop into flies. So we chose DJ694-driver which becomes 
spontaneously activated in fly muscle at eclosion and in our case leads to the loss of flight ability 
and an early death before day 20. It reaches a peak by day 30 (26). The DJ694 is ideal since the 
muscle tissue has a lot of mitochondria and we are able to bypass lethality in larval stage and 
observe effects in fully developed postmitotic organism, therefore increasing the relevance to 
humans. We gathered our EcoBI expressing flies at different time points and analyzed there mtDNA 
amount and presence of complex I subunits on protein levels and expression of several mRNA-s of 
mitochondrial-encoded genes. We used a line expressing only the R subunit as a control for our 
studies. 
 
Materials & methods 
 
-Drosophila melanogaster husbandry 
 
Fly food preparation and basic maintenance including the use of apparatus required for fly 
maintenance: the use CO2 pads for narcosis and the microscope for handling and making new 
stocks of flies. 
-RT-qPCR 
 
I used reverse-transcriptase quantitative polymerase chain reaction (RT-qPCR) and quantitative 
polymerase chain reaction qPCR to analyze the expression of mtDNA and mtDNA copy number 
genes in the mtEcoBI expressing D.melanogaster. The qPCR amplifies and measures the DNA 
quantity at the same time using a SYBR Green dye that fluoresces when bound to the dsDNA. We 
extracted total DNA from flies and measured mtDNA copy number using primers for the 
mitochondrial gene cytochrome C oxidase (Complex IV) subunit II (COX2) and for nuclear RpL32 
gene that served as a control. I had three biological replicates of each time point and ran the qPCR 
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using three experimental replicates. For the expression of mitochondrial genes measurements I used 
primer pairs for mitochondrial genes COX2, cytB, 16S and ND5. 
The DNA was extracted and purified using a spin-column based method, where nucleic acids were 
separated from the rest of cellular constituents through binding to a silica membrane. I extracted the 
RNA using commercial TRI reagent designed for RNA isolation followed by alcohol precipitation. I 
then removed residual DNA by DNase treatment and extracted the RNA with phenol/chloroform. 
Finally I precipitated the RNA again using sodium acetate and ethanol, dissolving the RNA in 
RNase free water. To make RNase free water I mixed a 0.1% DEPC (Diethylpyrocarbonate) 
solution and let it stand overnight before autoclaving it.  
 
  
 
 
 
 
RNA extraction protocol 
 
1. Collect 30 females or 40 males into Eppendorf, put on ice 
2. Add 200ul of Trizol, homogenize with plastic grinder 
3. Add 800ul of Trizol, continue grinding 
4. Incubate at room temperature for 5min, add 200ul of chloroform, shake for 15 sec 
and let stand at room temperature for 3min 
5. Centrifuge 12.000 G at 4°C for 15min 
6. Precipitate upper phase (0.6ml) with 0.5ml of ispropanol then mix 
7. Incubate 10min RT°C and centrifuge 12.000G at 4°C for 10min 
8. Wash pellet with 75% ethanol, spin 7500G for 5min and air dry for 5-10min. 
9. Dissolve RNA pellet in 180ul of DEPC-treated water, keep 10min at 55-60°C, 
measure concentration spectrophotometrically at OD260 
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DNase treatment of RNA samples 
1. Add 20ul of DNase buffer and 10 units of DNase I 
2. Incubate 37°C for 1 hour 
3. Extract RNA with 1 volume of phenol:chloroform:isoamyl alcohol 
4. Invert the tube to mix well and centrifuge at max speed for 5min at 4°C 
5. Add 1 volume of chloroform to upper phase and mix, spin as in step 4 
6. Collect upper phase and precipitate RNA with follows: 
 Add 1/10 volume of 3M NaAc 
 Add 2.5 volume of 95% EtOh and incubate -20°C overnight 
 Recover RNA by centrifuging at 11.000 rpm for 10min at 4°C 
 Wash pellet with 500ul of 75% EtOH 
 Air dry pellet at RT°C for 5-10min 
 Re-dissolve the pellet in 100ul of DEPC water and measure concentration 
 
 
 
 
 
– Protein analysis 
 
I used Western blotting which involves protein separation in polyacrylamid gels following transfer 
to nitrocellulose membrane and probing with specific antibodies. The antibodies we chose were 
raised against NDUFS3, GAPDH and ATP5α, the latter two serving as controls. The NDUFS3 is a 
complex I nuclear subunit, there is no available mitochondrial subunit antibody for complex I in 
Drosophila but its expression should correlate with the expression of mitochondrial subunits, as 
nuclear subunits of ETC complexes roughly correlate with the available amount of mitochondrial 
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subunits. (27). Thus by following nuclear subunit levels we can draw conclusion on overall 
presence of complex I. The GAPDH is housekeeping control protein involved in glycolysis, which 
has been used extensively in molecular biology experiments as a cytosolic control. The ATP5a is an 
important subunit to the ATP-synthase aka. Complex V, it was used as marker for mitochondrial 
amount. We used secondary antibodies conjugated with peroxidase which will emit light through 
chemiluminescence reaction. The results were visualized using X-ray film. After the taking the X-
ray film I used BioRad´s Quantity One software to quantify the western results. I had three 
biological replicates of each time point and ran two westerns using NDUFS3 and GAPDH 
antibodies and one copy of the ATP5α antibody. 
 
 
Fly Western Protocal 
 
 
 
1. Collect 35 flies into an eppendorf 
2. Add 500ul of western homogenization buffer and crush with pestle 
3. Incubate 30min on ice 
4. Centrifuge at 1500 rpm at 4°C for 5min, collect the supernatant (~450ul) 
5. Determine  concentration with Bradford assay 
6. Mix 100ul with 100ul 2xSDS loading buffer 
7. Incubate at 95°C for 5min 
8. Run gel (100V approximately 1 hour) 
9. Dry blot and mark membrane with pencil 
10. Shake for 1hr in Blocking solution  
11.  Add antibody 10 000 dilution with new Blocking solution 
12.  Probe with antibody at room temperature for 30min then overnight in 4°C and 30min at 
room temperature again. 
13. Wash the membrane three times with buffer (TBS 0.05% Tween 20)  
14.  Shake the membrane for 15min three times changing the buffer every time 
15.  Add secondary antibody (10 000 dilution) and shake it for at least 1hour 
16.  Wash the membrane as in step 12 and 13 
17.  Add 6ml per membrane of  ELC and wait for 5min before taking picture with x-ray film 
 
Western homogenization buffer:   40ml 
 
1.5% Triton X-100                                                             600ul 
Complete mini EDTA-free Protease Inhibitor                   2 tablets 
PBS                up to 40ml 
 
2XSDS loading buffer:  20ml 
 
130mM Tris-Cl, pH 8.0  2.6ml 
20 % Glycerol   4ml 
10% SDS    9.2ml 
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Bromophenol blue    2mg 
 2% DTT    400mg  
dH20     4.2ml 
 
 
 
 
10X Western Running Buffer    1l 
 
0.25M Trizma base    30.3g 
1.92M Glycine    144g 
1% SDS     10g add last 
 
 
Probing solution   250ml  (For two membranes) 
 
1xTBS     250ml 
5% milk powder   12,5g 
0.05% Tween 20    500ul (for 1litre) 
 
Tris-buffered Saline (TBS) X10   1l 
 
NaCl      80g 
KCl     2g 
Tris base    30g 
Adjust pH to 7.4 
 
 
Western results 
 
Fig.1 NDUFS3/ATP5α Western quantification females 
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Fig. 2 NDUFS3/GAPDH Western quantification females 
 
 
Fig.3 NDUFS3/ATP5α Western quantification males 
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Fig. 4 NDUFS3/GAPDH Western quantification males 
 
 
 
 
QPCR results 
 
 
Fig. 5 DNA QPCR COX2 male copy number 
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Fig.6 cDNA QPCR COX2 male expression 
 
 
Fig. 7 cDNA QPCR 16S male expression 
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Fig.8 cDNA QPCR ND5 male expression 
 
Fig.9 cDNA QPCR cytB male expression 
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Fig. 10 DNA QPCR COX2 female copy number 
 
 
Fig. 11 cDNA QPCR COX2 female expression 
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Fig. 12 cDNA QPCR 16S female expression 
 
 
 
Fig. 13 cDNA QPCR ND5 female expression 
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Fig.14 cDNA QPCR cytB female expression 
 
Results 
 
1. Mitochondrial protein expression (western) 
2.  
In the female EcoBI flies the NDUFS3/ATP5a ratio initially rises in days 0-4 but then decreases 
below starting levels (Fig.1). In NDUFS3/GAPDH ratio the EcoBI females also seem to rise in days 
0-4 and reach a plateau at days 4-6 before starting to fall from day 10 onward (Fig.2). No such 
decrease in NDUFS3 protein expression in comparison to ATP5a and GAPDH levels in the control 
flies. 
 In the EcoBI males the protein expression in the NDUFS3/ATP5a stays steady in the 0-6 days but 
then decreases to 30% on day 14 of the 0-day expression. (Fig.3). In the NDUFS3/GAPDH the 
EcoBI male fly expression levels rise in days 0-6 but also start ascending levels until the flies die at 
day 14 (Fig.4).  
We conclude that the Complex I subunit expression decreases in muscles in both the males and 
females flies in response to the EcoBI expression, suggesting drop in complex I amount. However, 
since these are results from just one biological replication, caution must be exercised when 
interpreting these results. 
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3. Mitochondrial copy number(qPCR) 
 
Male mtDNA copy number 
 
The mtDNA copy number in the EcoBI males flies decreases until day 4 and then steadily increases 
while the control flies copy number stays the same (Fig.5). This could be due to increased DNA 
replication caused by fragmentation of full-length mtDNA and because of the short amplicon the 
qPCR identifies both the fragmented and intact mtDNA.  
 
Female mtDNA copy number 
 
The mtDNA copy number in the female COX2 qPCR stay the same as the control with a peak at the 
last day which could be due to adaptation, since most of the flies had died and this causes a 
selection in the last days (Fig. 10).  
 
 
 
4.  Mitochondrial gene expression (RT-qPCR) 
 
Male mitochondrial gene expression 
 
The 16S expression levels stay the same compared to the control (Fig. 7). Expressions levels in the 
EcoBI decrease in both COX2 and ND5 below control strain levels after day 4 and 10 respectively 
(Fig.6 and 8). The cytB expression levels are generally higher than the control levels throughout the 
lifespan of the males flies in the control flies there is a fall in the expression levels after day 0  
(Fig.9).  
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Females mitochondrial gene expression 
The COX2 expression in the females flies also stays the same until the last day (Fig.11). The 16S 
has higher expression in the females than in the control (Fig.12). The ND5 expression does not 
differ from the control in the EcoBI female flies (Fig.13). The cytB expression are higher than the 
control in the females EcoBI flies (Fig. 14).  
 
Conclusions & discussion 
 
Protein analysis suggests that complex I decreases in response to EcoBI expression, this finding is 
supported by observed decrease in expression of ND5 subunit in males. Expression of complex IV 
mitochondrial subunit COX2 displayed similar reduction. Unchanged 16S levels probably reflect 
the higher stability of mitoribosomal RNA, which is not as sensitive to fluctuations in transcription 
as protein-coding mRNA-s. EcoBI degrades mtDNA (data not shown), but it also translocates it. 
This activity could possibly remove initiating/elongating transcription complexes from DNA and 
thus affect mitochondrial transcription. The substantial increase in cytB could reflect that the effect 
of EcoBI on transcription is more complex and specific than just plain overall inhibition. Although 
the coding sequence on both mt genome strands are being transcribed in their entirety, there are two 
major sites for transcription termination, implicating currently unknown mechanisms of regulation 
between initiation and termination. cytB gene is located between these two sites, suggesting that 
EcoBI activity might actually in some cases favor transcription by inhibiting termination. In any 
case, it is clear that EcoBI action interferes with normal expression of mitochondrial genes in 
muscles. These aforementioned effects on transcription were not observed in females. However, it is 
important to keep in mind that these full body lysates were used in analysis and mitochondria from 
muscles make up only a part of the total mitochondrial pool, especially in females where large 
portion of mitochondria are in embryos. 
The last day time points might not be reliable in the westerns and qPCRs since most of the flies 
gathered for testing were dead by the late time points (10-14 days) and this causes a selection of 
flies. Although these results are preliminary, they confirm the functionality of EcoBI in 
mitochondria and demonstrate its role in directly interfering with integrity and expression of mt 
genome. 
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